CLINICAL_TRIALS
trial_result
· 2017-02-23
Clinical Trial Update: A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes. [Phase 3]
Summary
A completed Phase 3 study evaluating the acute effects of vildagliptin on gastric emptying in patients with Type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED